摘要
目的:观察微小RNA-135b(miR-135b)、亮氨酸拉链肿瘤抑制基因1(LZTS1)信使核糖核酸(mRNA)、人附睾蛋白4(HE4)mRNA在卵巢癌中的表达水平及临床意义。方法:选取2018年1月至2020年11月本院接收的56例卵巢癌患者,收集手术切除的卵巢癌组织及其对应的癌旁组织。实时荧光定量PCR法检测两组卵巢组织中miR-135b、LZTS1 mRNA、HE4 mRNA的表达水平;分析卵巢癌组织中miR-135b、LZTS1 mRNA、HE4 mRNA表达水平与卵巢癌临床病理特征的关系及miR-135b、LZTS1 mRNA及HE4 mRNA表达水平对卵巢癌的诊断价值。结果:卵巢癌组miR-135b、HE4 mRNA表达水平均明显高于癌旁组(P均<0.05),LZTS1 mRNA表达水平明显低于癌旁组(P<0.05);卵巢癌组织中miR-135b、LZTS1 mRNA、HE4 mRNA表达水平与卵巢癌患者肿瘤分化程度、TNM分期及淋巴结转移相关(P均<0.05);miR-135b、LZTS1 mRNA、HE4 mRNA对卵巢癌诊断的曲线下面积(AUC)分别为0.781、0.755、0.773,对应截断值分别为1.25、0.87、1.20,此时对应灵敏度分别为74.5%、76.4%、72.7%,特异度分别为77.2%、72.9%、77.2%;三者联合诊断卵巢癌的AUC为0.943,其灵敏度、特异度分别为90.9%、84.2%。结论:卵巢癌患者卵巢癌组织中miR-135b、HE4 mRNA呈高表达,LZTS1 mRNA呈低表达,miR-135b、LZTS1 mRNA、HE4 mRNA对卵巢癌有一定诊断价值,三者联合可有效提高对卵巢癌的诊断效能。
Objective:To observe the expression level and clinical significance of microRNA-135b(miR-135b),leucine zipper tumor suppressor gene 1(LZTS1)messenger RNA(mRNA),human epididymal protein 4(HE4)mRNA in ovarian cancer.Methods:56 patients with ovarian cancer in our hospital from January 2018 to November 2020 were selected,and the ovarian cancer tissues and their corresponding adjacent tissues were collected.The expression levels of miR-135b,LZTS1 mRNA and HE4 mRNA in ovarian tissues of the two groups were detected by real time fluorescent quantitative PCR;the relationships between the expressions of miR-135b,LZTS1 mRNA,HE4 mRNA and the clinicopathological features of ovarian cancer were analyzed;and the diagnostic values of expression levels of miR-135b,LZTS1 mRNA and HE4 mRNA in ovarian cancer were analyzed.Results:The expression levels of miR-135b and HE4 mRNA in ovarian cancer group were significantly higher than those in adjacent group(P<0.05),and the expression level of LZTS1 mRNA was significantly lower than that in adjacent group(P<0.05);the expression levels of miR-135b,LZTS1 mRNA and HE4 mRNA in ovarian cancer were correlated with tumor differentiation,TNM stage and lymph node metastasis(P<0.05);the area under curve(AUC)of miR-135b,LZTS1 mRNA and HE4 mRNA in the diagnosis of ovarian cancer were 0.781,0.755 and 0.773,respectively,the corresponding cutoff values were 1.25,0.87 and 1.20,respectively,at this time,the corresponding sensitivities were 74.5%,76.4%and 72.7%,and the specificities were 77.2%,72.9%and 77.2%,respectively;the AUC of the combined diagnosis of ovarian cancer was 0.943,and the sensitivity and specificity were 90.9%and 84.2%respectively.Conclusions:MiR-135b and HE4 mRNA are highly expressed in ovarian cancer,LZTS1 mRNA is lowly expressed,miR-135b,LZTS1 mRNA and HE4 mRNA have certain diagnostic value for ovarian cancer,and the combination of them can effectively improve the diagnostic efficacy for ovarian cancer.
作者
章品
冯国琴
程文凤
章阳
ZHANG Pin(The First Hospital of Laohekou City in Hubei,Hubei Laohekou 441800,China)
出处
《河北医学》
CAS
2021年第9期1454-1460,共7页
Hebei Medicine
基金
湖北省卫生健康委员会科研项目,(编号:WJ2019M143)。
